Director Sharon Elad reports 2,167,671 Cognyte (CGNT) Ordinary Shares
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Cognyte Software Ltd. director Sharon Elad has filed an initial ownership report showing beneficial ownership of 2,167,671 Ordinary Shares. This total includes time-based restricted share units and performance share units that convert into Ordinary Shares as they vest over the next several years.
The holdings include awards such as RSUs granted on September 7, 2023 that vest on May 10, 2026, PSUs granted on March 26, 2024 and September 4, 2024 that vest on April 11, 2026, and multiple RSU grants from 2024 and 2025–2026 with staggered vesting dates through March 24, 2028.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Sharon Elad
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Ordinary Shares — 2,167,671 shares (Direct)
Footnotes (1)
- Includes 43,367 Ordinary Shares that are represented by restricted share units ("RSUs") that were granted on September 7, 2023, all of which vest on May 10, 2026. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement. Includes 297,470 Ordinary Shares that are represented by performance share units ("PSUs") that were granted on March 26, 2024, for which the performance conditions have been met, all of which vest on April 11, 2026. Each PSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement. Includes 123,974 Ordinary Shares that are represented by PSUs that were granted on September 4, 2024, for which the performance conditions have been met, all of which vest on April 11, 2026. Each PSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement. Includes 66,509 Ordinary Shares that are represented by RSUs that were granted on March 26, 2024, of which 13,302 vest on March 26, 2026, 13,302 vest on June 26, 2026, 13,302 vest on September 26, 2026, 13,302 vest on December 26, 2026 and 13,301 vest on March 26, 2027. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement. Includes 33,263 Ordinary Shares that are represented by RSUs that were granted on September 4, 2024, of which 5,544 vest on June 4, 2026, 5,544 vest on September 4, 2026, 5,544 vest on December 4, 2026, 5,544 vest on March 4, 2027, 5,544 vest on June 4, 2027 and 5,543 vest on September 4, 2027. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement. Includes 208,333 Ordinary Shares that are represented by RSUs that were granted on March 24, 2025, of which 69,444 vest on March 24, 2026, 17,361 vest on June 24, 2026, 17,361 vest on September 24, 2026, 17,361 vest on December 24, 2026, 17,361 vest on March 24, 2027, 17,361 vest on June 24, 2027, 17,362 vest on September 24, 2027, 17,361 vest on December 24, 2027 and 17,361 vest on March 24, 2028. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement. Includes 203,915 Ordinary Shares that are represented by RSUs that were granted on March 16, 2026, of which one-third (1/3) will vest on the first anniversary of the grant date and the remaining two-thirds (2/3) will vest in eight equal quarterly installments thereafter, over a total vesting period of three years.
FAQ
What does Sharon Elad report owning in Cognyte Software (CGNT) on this Form 3?
Sharon Elad reports beneficial ownership of 2,167,671 Ordinary Shares of Cognyte Software Ltd. This total includes both currently held shares and unvested restricted and performance share units that will settle into Ordinary Shares as vesting conditions are met.
Over what period do Sharon Elad’s Cognyte (CGNT) RSUs vest?
The RSUs vest on multiple schedules extending through March 24, 2028. Footnotes describe quarterly and annual vesting installments for grants dated March 26, 2024, September 4, 2024, March 24, 2025, and March 16, 2026, each RSU settling into one Ordinary Share.
Does the Cognyte (CGNT) Form 3 show any insider buy or sell transactions by Sharon Elad?
No buy or sell transactions are reported. The Form 3 functions as an initial statement of beneficial ownership, listing 2,167,671 Ordinary Shares held directly, including unvested RSUs and PSUs, without indicating any purchase or sale activity.
How are the March 16, 2026 RSUs for Sharon Elad in Cognyte (CGNT) structured?
The filing specifies 203,915 Ordinary Shares represented by RSUs granted on March 16, 2026. One-third vests on the first anniversary of the grant date, and the remaining two-thirds vest in eight equal quarterly installments over a total three-year vesting period.